Eltville, Germany

Hans Guehring

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Eltville, DE (2013 - 2018)
  • Geisenheim, DE (2022)
  • Geissenheim, DE (2022 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Innovations by Hans Guehring: A Profile of a Visionary Inventor

Introduction

Hans Guehring, a distinguished inventor based in Eltville, Germany, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 14 patents, he has been a driving force behind innovative technologies aimed at therapeutic advancements.

Latest Patents

Among his most notable inventions are immunoglobulins designed to bind to specific proteins, showcasing his expertise in therapeutic applications. One of his latest patents involves ADAMTS binding immunoglobulins, which relate to immunoglobulins that bind ADAMTS5. He has developed polypeptides that either comprise or consist of these immunoglobulins. This invention extends to various constructs, such as immunoglobulin single variable domains (ISVDs) and nucleic acids encoding these immunoglobulins. The applications of this invention are significant, particularly in pharmaceutical compositions aimed at prophylactic and therapeutic purposes.

Another significant patent by Guehring is related to MMP13 binding immunoglobulins. This invention focuses on immunoglobulins that specifically bind MMP13, leading to polypeptides and nucleic acids encoding these polypeptides. His innovations in this area provide methods for preparing such polypeptides and encompass pharmaceutical compositions that can be utilized for prophylactic, therapeutic, or diagnostic purposes, particularly emphasizing the inhibition of MMP13 activity.

Career Highlights

Hans Guehring has held positions at notable companies, including Merck Patent GmbH and Ablynx N.V. His work in these organizations has allowed him to further refine his inventions and contribute to the advancement of biomedical therapies.

Collaborations

Throughout his career, Guehring has collaborated with esteemed colleagues such as Christoph Hubertus Ladel and Sven Lindemann. These partnerships have played a significant role in enhancing the scope and impact of his research and inventions.

Conclusion

Hans Guehring stands out as a prominent figure in the innovation landscape of biomedical research. His extensive body of work, characterized by cutting-edge patents and collaborative endeavors, underscores his commitment to developing transformative therapeutic solutions. As he continues to push the boundaries of science, his contributions are poised to make a lasting impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…